Natures Sunshine Products

NATRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$288.040 M

$16.38 -19.47%

Close of 7 Aug 2026

Revenue

$480.1M

#1934 by revenue

Earnings

$19.5M

#1885 by earnings

Shares outstanding

17,595,520

Latest filing cover page

P/E ratio

14.8

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#239ImmuneeringIMRX$291.8M
#240Jupiter NeurosciencesJUNS$288.3M
#241Natures Sunshine ProductsNATR$288.0M
#242CellectisCLLS$285.0M
#243Eledon PharmaceuticalsELDN$284.8M

Where these numbers come from

Share counts and financials for Natures Sunshine Products are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.